EUVIMEDEUVIMED entdecken
Open Access

APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice

Ana C Valencia-Olvera, Deebika Balu, Annabelle Moore, Maitri Shah, Rebecca Ainis, Bingtao Xiang, Yaseen Saleh, Dongming Cai, Mary Jo LaDu, Leon M Tai

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-231210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Ana C Valencia-Olvera und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Apolipoprotein E2, Hippocampus. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

APOE2 lowers Alzheimer’s disease (AD) risk; unfortunately, the mechanism remains poorly understood and the use of mice models is problematic as APOE2 homozygosity is associated with hyperlipidemia. In this study, we developed mice that are heterozygous for APOE2 and APOE3 or APOE4 and overexpress amyloid-β peptide (Aβ) (EFAD) to evaluate the effect of APOE2 dosage on Aβ pathology. We found that heterozygous mice do not exhibit hyperlipidemia. Hippocampal but not cortical levels of soluble Aβ 42 followed the order E2/2FAD > E2/3FAD≤E3/3FAD and E2/2FAD > E2/4FAD < E4/4FAD without an effect on insoluble Aβ 42 . These findings offer initial insights on the impact of APOE2 on Aβ pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesApolipoprotein E2HippocampusAnimalsMiceApolipoprotein E3Apolipoprotein E4Apolipoproteins EHyperlipidemiasMice, Inbred StrainsMice, Transgenic

Stichwörter der Autor:innen

APOE2Alzheimer’s diseaseAβ42hyperlipidemiaplasma lipoproteins

Substanzen

Amyloid beta-PeptidesApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Apolipoproteins E

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA.
  • University of Illinois College of Medicine, IL, USA.
  • University of Miami/Jackson Healthcare System, Miami, FL, USA.
  • Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Research and Development Service, James J. Peters VA Medical Center, Bronx, NY, USA.
  • Department of Neurology, N. Bud Grossman Center for Memory Research and Care, University of Minnesota, Minneapolis, MN, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Valencia-Olvera, A. C., Balu, D., Moore, A., Shah, M., Ainis, R., Xiang, B., Saleh, Y., Cai, D., LaDu, M. J., & Tai, L. M. (2024). APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-231210

Vancouver

Valencia-Olvera AC, Balu D, Moore A, Shah M, Ainis R, Xiang B, et al. APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-231210

BibTeX
@article{ValenciaOlvera2024,
  author = {Valencia-Olvera, Ana C and Balu, Deebika and Moore, Annabelle and Shah, Maitri and Ainis, Rebecca and Xiang, Bingtao and Saleh, Yaseen and Cai, Dongming and LaDu, Mary Jo and Tai, Leon M},
  title = {APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-231210}
}
Kostenlos starten →